AMRI builds upon Indian operations
New York-based AMRI has added to its Indian operations, following the acquisition of another manufacturing plant in the country.
New York-based AMRI has added to its Indian operations, following the acquisition of another manufacturing plant in the country.
A new process for synthesising anti-inflammatory drugs such as ibuprofen could offer an environmentally friendly means of avoiding the 50 per cent waste seen with current methods of synthesis.
A tattoo you may not end up regretting could be one that provides a more efficient means of delivering DNA vaccines through the skin.
A proposed rule on labelling changes published by the Food and Drug Administration (FDA) has re-ignited the reliably inflammable debate over the role of pre-emption in US product liability cases.
Pharmaceutical Products Development (PPD) has announced it is moving into Russia, along with the news of positive trial results for its statin, although profits dipped again during the fourth quarter of 2007 as its R&D bill mounts.
Several contract manufacturers have recently made announcements regarding updates to their facilities.
SRI International, BASF, Richman Chemical, PDI and Codexis have all had people on the move in the world of pharmaceutical outsourcing.